Skip to main content

Maria Francesca Cortese

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Maria Francesca Cortese

Institutions of which they are part

Main researcher
Microbiology
Vall Hebron Institut de Recerca

Projects

Búsqueda de biomarcadores (inmunológicos y/o celulares) predictivos de respuesta virológica o de control de la infección en la hepatitis crónica D.

IP: Maria Buti Ferret
Collaborators: Maria Francesca Cortese
Funding agency: Instituto de Salud Carlos III
Funding: 220000
Reference: PI23/01065
Duration: 01/01/2024 - 31/12/2026

Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia (Clinical Biochemistry, Drug Delivery & Therapy, CB-DDT)

IP: Ibane Abasolo Olaortua
Collaborators: José Antonio Arranz Amo, Raquel Barquin Del Pino, Laura Conesa Milian, Clara Ramírez Serra, Yolanda Villena Ortiz, Joan López Hellin, Albert Blanco Grau, Roser Ferrer Costa, Joaquin Seras Franzoso, Diego Baranda Martínez-Abasca, Laura Castillo Ribelles, Clara Carnicer Cáceres, Marina Giralt Arnaiz, Ana Gomez Garcia, Simon Schwartz Navarro, Pablo Gabriel Medina, Zamira Vanessa Diaz Riascos, Marc Miquel Moltó Abad, Laura Castellote Bellés, Daniel Bravo Nieto, Luz María Cruz Carlos, Clara Sanz Gea, Alba Estela García Fernández, Maria del Pilar Reimundo Diaz-Fierros, Belen Garcia Prats, Noelia Díaz Troyano, JAUME VIMA BOFARULL, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Maria Francesca Cortese, Sandra Mancilla Zamora
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 01173
Duration: 01/01/2022 - 30/06/2025

Optimización del algoritmo diagnóstico para el cribado de infección por virus de la hepatitis D en la población atendida en el área de cobertura de la sanidad pública de la ciudad de Barcelona.

IP: Ariadna Rando Segura
Collaborators: Maria Buti Ferret, David Tabernero Caellas, Maria Francesca Cortese
Funding agency: GILEAD SCIENCES SLU
Funding: 27000
Reference: GILEAD/HEPATITIS/2022/RANDO
Duration: 22/02/2023 - 21/02/2025

Estudio de la quasiespecies del gen X en ARN circulante del virus de la hepatitis B (ARN-VHB): en búsqueda de nuevos factores pronósticos y dianas para terapia génica.

IP: -
Collaborators: Lluis Castells Fusté, Andrea Caballero Garralda, David Tabernero Caellas, Maria Francesca Cortese
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI18/01436
Duration: 01/01/2019 - 31/12/2022

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

Coro Bescós Atin

Coro Bescós Atin

Head of group
New Technologies and Craniofacial Microsurgery
Read more
Olga Boix Sanchez

Olga Boix Sanchez

Predoctoral researcher
Read more
Estevo Santamarina Pérez

Estevo Santamarina Pérez

Head of group
Research Group on Status Epilepticus and Acute Seizures
Read more
Merce  Ferrerons  Sanchez

Merce Ferrerons Sanchez

Main researcher
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.